99mTc-Daunorubicin a potential brain imaging and theranostic agent: Synthesis, quality control, characterization, biodistribution and scintigraphy

Nuclear Medicine and Biology

Volumn 40, Issue 1, 2013, Pages 148-152

  Faheem, A R ^a   Bokhari, T H ^a   Roohi, S ^b   Mushtaq, A ^b   Sohaib, M ^c  

^a GC UNIVERSITY   (Pakistan)

^b PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

^c PAKISTAN INSTITUTE OF ENGINEERING AND APPLIED SCIENCES   (Pakistan)

Author keywords

99mTc Daunorubicin; Biodistribution; Electrophoresis; HPLC; Radiolabeling; Scintigraphy

Indexed keywords

DAUNORUBICIN; STANNOUS CHLORIDE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SCINTISCANNING; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG RETENTION; DRUG STRUCTURE; DRUG UPTAKE; ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; LIGAND BINDING; LIPOPHILICITY; MALE; NEUROIMAGING; NONHUMAN; PAPER CHROMATOGRAPHY; PH; QUALITY CONTROL; RADIOASSAY; RADIOCHROMATOGRAPHY; RAT; ROOM TEMPERATURE; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; CHEMISTRY TECHNIQUES, SYNTHETIC; DAUNORUBICIN; HUMANS; MALE; ORGANOTECHNETIUM COMPOUNDS; QUALITY CONTROL; RABBITS; RADIOCHEMISTRY; RADIONUCLIDE IMAGING; RATS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84871920469     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.08.010     Document Type: Article

References (22)

1. Ell P.J., Jarritt P.H., Costa D.C., Cullum I.D., Lui D. Functional imaging of the brain. Semin Nucl Med 1987, 17:214-229.
2. 99mTc-labelled ethylene dicysteine diethyl ester (99mTc-ECD). Nucl Med Biol 1998, 25(6):569-575.
3. 99mTc-HMPAO labeling. Nucl Med Biol 2011, 38:1175-1182.
4. Hirata M., Magata Y., Ohmomo Y., Saji H., Murakami K., Takagaki T., et al. Evaluation of radioiodinated iodoclorgyline as a SPECT radiopharmaceutical for MAO-A in the brain. Nucl Med Biol 1995, 22:175-180.
5. 123I]-p-iodoamphetamine in haemorrhagic and ischaemic brain. Nucl Med Biol 1993, 20:983-990.
6. Bergmann R., Brust P., Kampf G., Coenen H.H., Stöcklin G. Evaluation of radioselenium labeled selenomethionine, a potential tracer for brain protein synthesis by PET. Nucl Med Biol 1995, 22:475-481.
7. Fujibayashi Y., Taniuchi H., Waki A., Yokoyama A., Ishii Y., Yonekura Y. Intracellular metabolism of 99mTc-d, l-HMPAO in vitro: a basic approach for understanding the hyperfixation mechanism in damaged brain. Nucl Med Biol 1998, 25:375-378.
8. Cutler C.S., Giron M.C., Reichert D.E., Snyder A.Z., Herrero P., Anderson C.J., et al. Evaluation of gallium-68 tris (2-mercaptobenzyl) amine: a complex with brain and myocardial uptake. Nucl Med Biol 1999, 26:305-316.
9. 11C]methoxy-norchloroprogabidic acid, a potential PET tracer for GABA receptors in the brain. Nucl Med Biol 1999, 26:323-325.
10. 76Br] FBAU 3',5'-dibenzoate as a lipophilic prodrug for brain imaging. Nucl Med Biol 2002, 29:527-535.
11. 99mTc nitrido complex for cerebral imaging. Nucl Med Biol 2002, 29:665-669.
12. Holman B.L., Lee R.G.L., Hill T.C., et al. A comparison of two cerebral blood flow tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIMPDM. J Nucl Med 1984, 25:25-30.
13. Neirinckx R.D., Canning L.R., Piper I.M., et al. Technetium-99md, l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987, 28:191-202.
14. Sharp P.F., Smith F.W., Gemmell H.G., et al. Technetium-99m-HMPAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986, 27:171-177.
15. Walovitch R.C., Hill T.C., Garrity S.T., et al. Characterization of technetium-99 m-L, L-ECD for brain perfusion imaging, part 1: pharmacology of technetium-99 m-ECD in nonhuman primates. J Nucl Med 1989, 30:1892-1901.
16. Leveille J., Demonceau G., De Roo M., et al. Characterization of technetium-99 m-L, L-ECD for brain perfusion imaging, part 2: biodistribution and brain imaging in humans. J Nucl Med 1989, 30:1902-1910.
17. Vallabhajosula S., Zimmerman R.E., Picard M., et al. Technetium-99m-ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 1989, 30:599-604.
18. Weiss R.B. The anthracyclines: will we ever find a better doxorubicin?. Sem Oncol 1992, 19:670-686.
19. Tan C., Tasaka H., Yu K.P., Murphy M.L., Karnofsky D.A. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 1967, 20:333-353.
20. Mortensen M.E., et al. Inadvertent intrathecal injection of daunorubicin with fatal outcome. Med Pediatr Oncol 1992, 20:249-253.
21. Cerubidine (daunorubicin HCl) injection retrieved on 20 July 2012. http://www.rxlist.com/cerubidine-drug.htm.
22. Shen LH, Tseng YC, Liao MH, Fu YK, The role of molecular imaging in the diagnosis and management of neuropsychiatric disorders, J. Biomed. Biotech, Volume 2011, Article ID 439397, 11 pages http://dx.doi.org/10.1155/2011/439397.